The Oncology Institute Statistics
Total Valuation
TOI has a market cap or net worth of $34.24 million. The enterprise value is $88.24 million.
| Market Cap | 34.24M |
| Enterprise Value | 88.24M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TOI has 74.44 million shares outstanding. The number of shares has increased by 1.07% in one year.
| Shares Outstanding | 74.44M |
| Shares Change (YoY) | +1.07% |
| Shares Change (QoQ) | +0.38% |
| Owned by Insiders (%) | 19.84% |
| Owned by Institutions (%) | 55.61% |
| Float | 36.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.10 |
| Forward PS | 0.11 |
| PB Ratio | 0.83 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.09, with a Debt / Equity ratio of 2.90.
| Current Ratio | 3.09 |
| Quick Ratio | 2.73 |
| Debt / Equity | 2.90 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.46 |
Financial Efficiency
Return on equity (ROE) is -90.70% and return on invested capital (ROIC) is -38.55%.
| Return on Equity (ROE) | -90.70% |
| Return on Assets (ROA) | -26.80% |
| Return on Capital (ROIC) | -38.55% |
| Revenue Per Employee | $428,391 |
| Profits Per Employee | -$72,210 |
| Employee Count | 800 |
| Asset Turnover | 1.59 |
| Inventory Turnover | 26.16 |
Taxes
| Income Tax | -80,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.30% in the last 52 weeks. The beta is 0.66, so TOI's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -19.30% |
| 50-Day Moving Average | 0.68 |
| 200-Day Moving Average | 1.48 |
| Relative Strength Index (RSI) | 40.18 |
| Average Volume (20 Days) | 123,944 |
Short Selling Information
The latest short interest is 232,581, so 0.31% of the outstanding shares have been sold short.
| Short Interest | 232,581 |
| Short Previous Month | 205,543 |
| Short % of Shares Out | 0.31% |
| Short % of Float | 0.65% |
| Short Ratio (days to cover) | 0.84 |
Income Statement
In the last 12 months, TOI had revenue of $342.71 million and -$57.77 million in losses. Loss per share was -$0.81.
| Revenue | 342.71M |
| Gross Profit | 57.44M |
| Operating Income | -62.12M |
| Pretax Income | -57.85M |
| Net Income | -57.77M |
| EBITDA | -45.64M |
| EBIT | -51.74M |
| Loss Per Share | -$0.81 |
Balance Sheet
The company has $65.83 million in cash and $119.84 million in debt, giving a net cash position of -$54.00 million or -$0.73 per share.
| Cash & Cash Equivalents | 65.83M |
| Total Debt | 119.84M |
| Net Cash | -54.00M |
| Net Cash Per Share | -$0.73 |
| Equity (Book Value) | 41.30M |
| Book Value Per Share | 0.55 |
| Working Capital | 95.42M |
Cash Flow
In the last 12 months, operating cash flow was -$36.75 million and capital expenditures -$3.34 million, giving a free cash flow of -$40.08 million.
| Operating Cash Flow | -36.75M |
| Capital Expenditures | -3.34M |
| Free Cash Flow | -40.08M |
| FCF Per Share | -$0.54 |
Margins
Gross margin is 16.76%, with operating and profit margins of -18.13% and -16.86%.
| Gross Margin | 16.76% |
| Operating Margin | -18.13% |
| Pretax Margin | -16.88% |
| Profit Margin | -16.86% |
| EBITDA Margin | -13.32% |
| EBIT Margin | -15.10% |
| FCF Margin | -11.70% |
Dividends & Yields
TOI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.07% |
| Shareholder Yield | -1.07% |
| Earnings Yield | -168.71% |
| FCF Yield | -117.06% |
Analyst Forecast
The average price target for TOI is $2.50, which is 443.48% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.50 |
| Price Target Difference | 443.48% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TOI has an Altman Z-Score of 0.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.39 |
| Piotroski F-Score | 2 |